Q2 revenue and EBITDA growth diverge
Q2 revenue grew 26% and underlying volume 14%, while normalized EBITDA increased 11%; earnings did not keep pace with sales.
Watch: Monitor whether EBITDA growth catches up with revenue growth.
Home / Research / AWL Agri Business Limited
Q2 revenue and EBITDA growth diverge
https://www.bseindia.com/xml-data/corpfiling/AttachLive/8450969a-96f3-4f56-9513-305ba1f6fe30.pdf
https://www.bseindia.com/xml-data/corpfiling/AttachLive/8450969a-96f3-4f56-9513-305ba1f6fe30.pdf
https://www.bseindia.com/xml-data/corpfiling/AttachLive/8450969a-96f3-4f56-9513-305ba1f6fe30.pdf
https://www.bseindia.com/xml-data/corpfiling/AttachLive/8450969a-96f3-4f56-9513-305ba1f6fe30.pdf
Q2 revenue grew 26% and underlying volume 14%, while normalized EBITDA increased 11%; earnings did not keep pace with sales.
Watch: Monitor whether EBITDA growth catches up with revenue growth.
₹22,202 crore is Q2 revenue; ₹42,250 crore is H1 revenue, a different period length.
Watch: Compare H1 against the previous H1 and Q2 against the previous Q2.
Normalized EBITDA was ₹623 crore in Q2 FY27, versus ₹559 crore in Q2 FY26 and ₹725 crore in Q1 FY27.
Watch: Keep the reported-versus-normalized reconciliation visible when comparing periods.
Normalized H1 EBITDA advanced from ₹1,078 crore to ₹1,347 crore, consistent with around 25% growth.
Watch: Recheck normalized and reported series separately in H2.
Reporting period: quarter ended 30 September 2026. Investment stance: WATCH, conditional on earnings quality and cash conversion. Evidence: [S1] BSE-filed earnings-call transcript, 3 November 2026; [S2] BSE-filed investor presentation, 27 October 2026.
| Consolidated indicator | Q2 FY27 | Comparison | Reading |
|---|---|---|---|
| Revenue from operations | ₹22,202 crore | +26% YoY | Price/mix and 14% underlying volume growth both matter |
| Underlying volume growth | 14% | YoY | Stronger than edible-oil growth alone |
| EBITDA excluding other income | ₹623 crore | +11% YoY | Slower than revenue growth |
| Food & FMCG revenue | ₹2,216 crore | +32% YoY | Diversification growing |
| Food & FMCG EBITDA | ₹71 crore | -7% YoY | Revenue growth not translating into profit |
| H1 revenue | ₹42,250 crore | +22% YoY | Six-month scale |
| H1 EBITDA excluding other income | ₹1,347 crore | +25% YoY | H1 better than Q2 |
All figures in this dashboard are issuer-presented consolidated figures [S2], except management's 14% underlying-volume commentary, also stated in [S1]. The issuer distinguishes normalized gross profit from reported gross profit because of derivative reclassification. Do not equate these with statutory profit.
Five decision takeaways. (1) Revenue grew 26% but EBITDA only 11%, so operating leverage has not kept pace with sales [S2]. (2) Underlying volume growth of 14% indicates meaningful real throughput, not merely commodity-price inflation [S1]. (3) Food & FMCG grew 32% to ₹2,216 crore, yet EBITDA fell 7% to ₹71 crore: mix growth is not synonymous with margin improvement [S2]. (4) Edible oils recorded 5% volume growth, slower than group underlying growth [S1]. (5) Industry Essentials recorded 25% volume growth; management said oleochemicals and specialty chemicals are about 45% of segment revenue [S1]. These indicators warrant monitoring before a stronger investment conclusion.
AWL combines a large edible-oil franchise, a growing branded staples platform and a chemicals/industry-essentials operation. The investment question is whether the business can turn rapid sales and volume growth into durable operating earnings, especially as the product mix shifts. The company is not simply a high-growth packaged-food pure play: its commodity-linked oil operations dominate the revenue mix, while food and specialty chemicals are still developing their contribution [S1][S2].
WATCH rather than a price-based BUY or SELL. No current market price, enterprise value, net debt, diluted shares or independently verified forward earnings multiple is provided in these two source documents. Accordingly this report cannot calculate a defensible price target or margin of safety. A valuation premium would demand sustained food-margin improvement, better cash conversion and evidence that specialty-chemical value addition persists through raw-material cycles. A discount would be justified if earnings remain disproportionately exposed to oil-price movements and food growth consumes working capital without expanding returns.
For Q2 FY27, AWL presented consolidated revenue from operations of ₹22,202 crore, up 26% YoY, with underlying volume growth of 14%. EBITDA excluding other income was ₹623 crore, up 11% YoY. The implied EBITDA-to-revenue ratio is about 2.81%; this is a derived division of issuer-presented figures, not an additional reported metric [S2]. The 15-percentage-point gap between revenue and EBITDA growth suggests pressure from cost, mix or timing effects, but the source data alone do not isolate their respective contributions.
For H1 FY27, consolidated revenue was ₹42,250 crore, up 22% YoY, and EBITDA excluding other income was ₹1,347 crore, up 25% YoY [S2]. The implied H1 EBITDA/revenue ratio is about 3.19%, above Q2's approximately 2.81%. The contrast is important: a six-month aggregate can obscure quarter-specific pressure. It is not appropriate to extrapolate the H1 growth rate automatically into H2.
The presentation's gross-profit bridge lists Q2 FY27 reported gross profit of ₹2,112 crore, Q1 FY27 ₹2,201 crore and Q2 FY26 ₹2,049 crore. The company explains that since Q4 FY24 derivative gains and losses have been reclassified from cost of materials consumed to other income or expenses. Therefore reported gross-profit comparisons and management-normalized comparisons may differ [S2]. The analyst should retain both series, and avoid silently treating adjusted EBITDA, normalized gross profit and statutory profit as interchangeable.
Food & FMCG's ₹2,216 crore quarterly revenue was 32% higher YoY, but its ₹71 crore EBITDA was 7% lower YoY [S2]. The approximate quarterly segment EBITDA margin is 3.20%, derived from the reported pair; the presentation rounds the margin to 3%. This is the clearest example of revenue strength without corresponding earnings conversion. H1 food revenue was ₹3,943 crore, up 27%, and food EBITDA ₹175 crore, up 2%; the approximate H1 margin was 4.44%, based on the disclosed amounts. The issuer's margin conventions and rounding should prevail in comparisons.
Edible oil remains the scale engine. Management reported 5% quarterly volume growth and pointed to domestic mustard, groundnut and cottonseed oil as areas of growth [S1]. This category's economics are sensitive to procurement prices, refining spreads, branded versus loose consumption and the speed at which retail prices respond to input changes. Higher rupee sales can arise without a comparable rise in tonnes or contribution. The analytical focus is therefore volume, realization, gross spread and inventory exposure rather than topline alone.
Food & FMCG is the portfolio-diversification engine. Management described double-digit growth in rice and flour, double-digit Kohinoor growth and Fortune pulses growing over 40% YoY with quarterly sales crossing ₹100 crore [S1]. The latter is management commentary, not an independently verified subsegment financial statement. The strategy depends on branded penetration in staples, regional assortment and distribution expansion, including quick commerce. Growth may require promotional spending, shelf placement, logistics and receivables; that can suppress near-term segment margins even when brands gain share.
The presentation shows Food & FMCG at roughly 10% of Q2 FY27 revenue mix, Industry Essentials 13% and edible oils 77%, versus 10%, 10% and 79% respectively in the comparative presentation graphic [S2]. These percentages are rounded and should not be used to reconstruct exact segment rupee figures. Management also cited trailing-twelve-month revenue above ₹1,400 crore in health and convenience products [S1], but no full standalone margin bridge is established here. This is a strategic opportunity, not yet evidence of high returns.
Industry Essentials recorded 25% volume growth [S1]. Management said oleochemicals and specialty chemicals account for approximately 45% of that segment's revenue, and discussed access to Wilmar Group R&D and formulation capability. The segment's higher-value mix could improve resilience, but actual realized contribution margins, customer concentration and incremental invested capital need to be monitored. An increase in specialty mix alone is not proof of superior cash returns.
Management's central operating proposition is to use existing brands, procurement, manufacturing and distribution to build a larger food platform [S1]. This is operationally plausible because adjacent staples can share customer access, but economics differ by category. Basmati rice, pulses, flour and convenience products have different sourcing cycles, inventory needs, competitive sets and promotional intensity. Investors should not assume that one distribution network produces identical margins across products.
Management identified branded penetration and regional assortment as opportunities, while the edible-oil business aims to preserve market share through a volatile commodity cycle [S1]. These are forward-looking strategic statements, not contracted outcomes. The next quarterly call should be evaluated against the prior claims: did pulses remain strong, did Food & FMCG EBITDA improve, and did Industry Essentials preserve volume momentum? If not, management should explain whether the variance reflects pricing, mix, investment, raw-material cost or channel incentives.
The 27 October call includes a management presentation followed by analyst questions [S1]. This report does not claim every Q&A answer was independently corroborated. The strongest use of Q&A is as a challenge framework: ask for segment profitability after distribution spending, inventory days, capital committed to new categories and the economic rationale for specialty-chemical investment. Such questions are monitoring tests, not representations that management supplied particular undisclosed numbers.
An EBITDA increase is not equivalent to operating cash flow. Edible-oil procurement, seasonal staples inventories and channel receivables can absorb substantial working capital. Derivative-related classification changes also require care when comparing accounting gross profit and operating economics [S2]. The supplied evidence does not establish a reliable consolidated operating cash flow, net-debt or capex series for this report; these are intentionally not invented.
For valuation, investors should retrieve the statutory H1 cash-flow statement and reconcile operating cash generation to EBITDA, taxes, interest and changes in inventory, receivables and payables. Capital expenditure should be separated into maintenance, debottlenecking, new product capacity and specialty-chemical expansion. The return on incremental capital matters more than aggregate capacity announcements. Without a verified cash-flow bridge, neither a free-cash-flow yield nor a debt paydown timetable can be responsibly estimated.
The working-capital risk is asymmetric: high commodity prices can inflate revenue and inventory funding simultaneously. A rising sales line alongside rising receivables or inventory may not strengthen owner earnings. Conversely, more efficient inventory turns and improved payment collection can release cash without any acceleration in accounting revenue.
Bull case, conditional: food volumes compound, branded penetration strengthens, Food & FMCG margins recover from the approximately 3% Q2 level, and specialty chemicals sustain mix improvement. Group EBITDA then grows faster than sales while working capital remains controlled. This case requires evidence across at least several quarters; it is not a forecast of earnings or share price.
Base case, conditional: the edible-oil franchise continues to grow volumes modestly, food revenue expands faster but margins remain uneven, and Industry Essentials contributes growth without a proven step-change in consolidated cash returns. In this scenario AWL remains a diversified, commodity-sensitive consumer/industrial platform, and valuation should be conservative until profit conversion improves.
Bear case, conditional: commodity-price volatility compresses spreads, aggressive food distribution investment holds margins down, and cash becomes trapped in inventories or receivables. EBITDA then trails revenue for longer, undermining any premium growth narrative. A persistent divergence between food sales and food EBITDA would be an early warning.
These scenarios are directional decision frameworks, not probabilistic models or management guidance. No invented terminal multiples, targets, probability weights or forward profit estimates are attached. The bull case is falsified by continued food-margin erosion; the base case by a sustained break in oil volumes or cash conversion; the bear case by clear, repeatable margin and cash improvements.
Investor fit: WATCH for investors evaluating a multi-year branded-food transition with substantial edible-oil and industrial exposure. It is not possible to label the stock cheap or expensive without an as-of-date share price and verified capital structure. A momentum trader would additionally need independent price/technical evidence, which is outside these issuer filings.
Before entry: obtain the latest statutory consolidated results, H1 cash-flow statement, debt and cash balances, diluted share count and market valuation. Rebuild the reported-versus-normalized profit bridge. Compare food and oil contribution across at least four quarters. Require a valuation margin of safety that reflects commodity risk and uncertainty around new categories; no numeric entry price is justified by these documents alone.
Quarterly monitoring table:
| Test | Q2 FY27 baseline | Positive confirmation | Negative signal |
|---|---|---|---|
| Group volume | +14% YoY [S1] | Broad-based sustainable volume | Growth driven mostly by prices |
| Group EBITDA | ₹623 crore, +11% YoY [S2] | Growth converges with or exceeds revenue | Continued material lag |
| Food sales | ₹2,216 crore, +32% YoY [S2] | Strong branded growth | Sharp deceleration |
| Food EBITDA | ₹71 crore, -7% YoY [S2] | Margin recovery | Profit falls despite sales growth |
| Oil volumes | +5% YoY [S1] | Share and volume resilience | Sustained contraction |
| Industry Essentials volume | +25% YoY [S1] | Profitable specialty-led expansion | Mix growth without returns |
| Cash conversion | Not established here | Verified CFO and working-capital improvement | EBITDA not converting to cash |
Action discipline: do not chase a headline revenue beat without checking margin and cash. Revisit after the next quarter's presentation and earnings call, updating only the changed facts. Record the valuation assumptions explicitly and keep management ambitions separate from observed performance.
[S1] AWL Q2 FY27 earnings-call transcript, call 27 October 2026, exchange filing 3 November 2026. [S2] AWL Q2/H1 FY27 investor presentation, exchange filing 27 October 2026.
Source-based research, not an independent audit, investment recommendation or price-target model. Figures are consolidated unless explicitly indicated. The presentation uses EBITDA excluding other income and discusses derivative reclassification; statutory PAT, cash flow, capex, debt and valuation have not been inferred where unavailable.
https://www.bseindia.com/xml-data/corpfiling/AttachLive/8450969a-96f3-4f56-9513-305ba1f6fe30.pdf
https://www.bseindia.com/xml-data/corpfiling/AttachLive/8450969a-96f3-4f56-9513-305ba1f6fe30.pdf
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b209839-a497-4cd0-af3c-71067373297d.pdf
https://www.bseindia.com/xml-data/corpfiling/AttachLive/8450969a-96f3-4f56-9513-305ba1f6fe30.pdf
This is dated research, not a live market quote. Scenarios and historical performance are not guarantees.